Overview

ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"

Status:
Terminated
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To determine if low-dose enoximone therapy is an effective treatment for advanced chronic heart failure.
Phase:
Phase 3
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Enoximone